In conclusion, our data showed that the constructed OncoAd.RGD-hTERT-TRAIL exhibited robust effect in inhibition bladder cancer initiating cells in vitro and in vivo, suggesting the potential anti-tumor possibility for bladder cancer therapy. This evidence concerns the gene TNFSF10 and neoplasm.